Human mutation · 2017
Severe infantile isolated exocrine pancreatic insufficiency caused by the complete functional loss of the SPINK1 gene.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Venet Théa, Masson Emmanuelle, Talbotec Cécile, Billiemaz Kareen, Touraine Renaud, Gay Claire, Destombe Sylvie, Cooper David N, Patural Hugues, Chen Jian-Min, Férec Claude
Аннотация
Exocrine pancreatic insufficiency (EPI) is rare in children, with most if not all cases occurring as part of syndromic conditions such as cystic fibrosis and Shwachman-Diamond syndrome. Here we report two cases, both presenting with severe EPI around 5 months of age. Characterized by diffuse pancreatic lipomatosis, they otherwise exhibited no remarkable deficiencies in other organs. Novel non-identical homozygous variants (a deletion removing the entire SPINK1 gene and an insertion of a full-length inverted Alu element into the 3'-untranslated region of the SPINK1 gene) resulting in the complete functional loss of the SPINK1 gene (encoding pancreatic secretory trypsin inhibitor) were identified in each patient. Having correlated our findings with current knowledge of SPINK1's role in exocrine pancreas pathophysiology, we propose that complete and partial functional losses of the SPINK1 gene are associated with quite distinct phenotypes, the former causing a new pediatric disease entity of severe infantile isolated EPI.
Предметные рубрики MeSH
Alu ElementsBone Marrow DiseasesCystic FibrosisExocrine Pancreatic InsufficiencyFemaleGenetic Predisposition to DiseaseHomozygoteHumansInfantLipomatosisMagnetic Resonance ImagingMutagenesis, InsertionalPancreatic DiseasesPhenotypeSequence DeletionShwachman-Diamond SyndromeTrypsin Inhibitor, Kazal Pancreatic